NASDAQ:BVXV

BiondVax Pharmaceuticals Ltd.

Stock

USD

Last Close

1.35

06/09 19:59

Market Cap

4.97M

Beta: 2.47

Volume Today

22.67K

Avg: 41.50K

PE Ratio

0.59

PFCF: −3.53

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
revenue								2.75M -
cost of revenue
gross profit								2.75M -
selling and marketing expenses
general and administrative expenses		3.26M -	4.06M 24.33%	4.75M 17.03%	5.09M 7.16%	9.35M 83.81%	16.14M 72.50%	23.98M 48.61%
selling general and administrative expenses	2.65M -	3.26M 23.17%	4.06M 24.33%	4.75M 17.03%		9.35M -		23.98M -	5.30M 77.91%
research and development expenses	5.49M -	7.91M 43.95%	7.79M 1.42%	18.78M 140.92%		68.64M -		10.34M -	5.76M 44.25%
other expenses	2.65M -	133K 94.98%	48K 63.91%	130K 170.83%	65K 50%	352K 441.54%	-23.47M 6,768.94%	509K 102.17%
cost and expenses	8.14M -	11.30M 38.82%	11.90M 5.28%	23.66M 98.79%		78.35M -		34.83M -	11.06M 68.24%
operating expenses	8.14M -	11.30M 38.82%	11.90M 5.28%	23.66M 98.79%	20.46M 13.50%	78.35M 282.89%	-2.28M 102.91%	34.83M 1,627.06%	11.06M 68.24%
interest expense						14.92M -		10.83M -	-5.26M 148.61%
ebitda	-7.46M -	-10.68M 43.00%	-11.28M 5.66%	-12.30M 9.08%		-76.86M -		-32.44M -	-10.50M 67.64%
operating income	-8.14M -	-11.30M 38.82%	-11.90M 5.28%	-23.66M 98.79%		-78.35M -		-34.83M -	-11.06M 68.24%
depreciation and amortization	677K -	628K 7.24%	621K 1.11%	440K 29.15%	260K 40.91%	1.49M 474.23%	2.44M 63.16%	2.38M 2.09%	562K 76.44%
total other income expenses net	378K -	1.09M 189.15%	2.66M 143.46%	-10.91M 510.11%	2.84M 125.99%	-30.84M 1,187.55%		-5.15M -	5.26M 202.25%
income before tax	-7.76M -	-10.20M 31.36%	-9.18M 9.95%	-34.55M 276.21%		-109.19M -		-39.98M -	-5.80M 85.50%
income tax expense		-11K -	-55K 400%	10.89M 19,909.09%	2.88M 73.52%	14.92M 417.09%		10.83M -	-5.26M 148.61%
net income	-7.76M -	-10.20M 31.36%	-9.18M 9.95%	-34.55M 276.21%	-23.29M 32.58%	-124.11M 432.82%	6.82M 105.49%	-50.81M 845.54%	-531K 98.95%
weighted average shs out	326.74K -	263.81K 19.26%	337.74K 28.03%	502.58K 48.80%	653.55K 30.04%	816.63K 24.95%	1.11M 35.70%	1.41M 27.37%	1.89M 33.57%
weighted average shs out dil	326.74K -	263.81K 19.26%	337.74K 28.03%	502.58K 48.80%	653.55K 30.04%	816.63K 24.95%	1.11M 35.70%	1.41M 27.37%	754.08B 53,425,933.48%
eps	-23.76 -	-38.66 62.71%	-27.19 29.67%	-68.75 152.85%	-35.64 48.16%	-151.98 326.43%	6.15 104.05%	-36 685.37%	-0.28 99.22%
epsdiluted	-23.76 -	-38.66 62.71%	-27.19 29.67%	-68.75 152.85%	-35.64 48.16%	-151.98 326.43%	6.15 104.05%	-36 685.37%	0 100%

All numbers in USD (except ratios and percentages)